9:22 AM
Leo Group India
| ||
| Dr. Reddy's, Sun Pharma, 9 others get FDA nod for generic version of Plavix domain-B This will allow Dr. Reddy's Laboratories, Gate Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals to manufacture 300 milligram (mg) clopidogrel, while Apotex Corporation, Aurobindo Pharma, Mylan Pharmaceuticals, Roxane Laboratories, ... See all stories on this topic » | ||
| Panel for control of drug prices Deccan Herald Deposing before the GoM on pharmaceutical price headed by Agriculture Minister Sharad Pawar, Congress Lok Sabha member Jyoti Mirdha and voluntary outfit All India Drug Action Network demanded price control from the government on all drugs and not ... See all stories on this topic » | ||
| US FDA okays Ambit Biosciences & Teva's IND for CEP-32496, a novel BRAF inhibitor pharmabiz.com Ambit Biosciences, a private biopharmaceutical company, and Israel based Teva Pharmaceutical Industries Limited, have received Investigational New Drug application (IND) clearance from the US Food and Drug Administration (FDA) for CEP-32496, ... See all stories on this topic » | ||
| MP joins drug price chorus Calcutta Telegraph Mirdha said the National Pharmaceutical Pricing Policy (NPPP) 2011 had suggested price controls on 348 of nearly 900 drug molecules and had thus left the door open for companies to shift from regulated to unregulated drugs. The NPPP was prepared by the ... See all stories on this topic » | ||
| Approval of Generic Clopidogrel a Boon for Patients or Payors? Family Practice News Digital Network In the FDA statement announcing the approval, Keith Webber, Ph.D., deputy director of the Office of Pharmaceutical Science in the FDA's Center for Drug Evaluation and Research, referred to the importance of having effective and affordable medications ... See all stories on this topic » | ||
| ||
| GoM on pharma policy to meet again next week Hindu Business Line The Group of Ministers (GoM) on National Pharmaceutical Policy would meet again next week after the Parliament session is over on May 22. The GoM met for the second time this week. "We will sit sometime after the (Parliament) Session. See all stories on this topic » | ||
| Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions ... Sacramento Bee By Watson Pharmaceuticals, Inc. PARSIPPANY, NJ, May 18, 2012 -- /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty global pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive ... See all stories on this topic » | ||
| India's pharma, consumer stocks shine MarketWatch MUMBAI (MarketWatch) – While Indian stocks are among the worst performers among Asian peers this year, the pharmaceutical and consumer discretionary sectors have been booming since March. Both sectors can be considered more than defensive plays in the ... See all stories on this topic » | ||
| Sagent Pharma launches irinotecan Hcl injection in single dose vials pharmabiz.com Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, has launched irinotecan injection, the generic form of the chemotherapy drug Camptosar, ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment